-
effectivehealthcare.ahrq.gov/products/medicine-safety-databases/abstract
January 01, 2005 - the initial measure set selected and determine which indicators will be the focus of the validation phase
-
effectivehealthcare.ahrq.gov/sites/default/files/01_-arthritis_potential_high_impact_june_2012.pdf
January 01, 2012 - Results
The table below lists the seven topics for which (1) preliminary phase III or later phase data … Expert comments led to designation of one RA therapy in
phase III development as having high potential … In the most recent phase III trials, tofacitinib was
administered twice daily in 5 and 10 mg doses. … In phase III trials, patients treated with
tofacitinib demonstrated improvements in signs and symptoms … Pfizer's tofacitinib meets endpoints in final
phase III trials.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0163_09-03-2009.pdf
January 01, 2009 - populations,
interventions, comparators, and outcomes, will be further developed in the refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0310_05-13-2008.pdf
January 01, 2008 - populations, interventions, comparators, and outcomes, will be further developed in the refinement
phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0119_06-17-2009.pdf
January 01, 2009 - populations, interventions, comparators, and outcomes, will be further developed in the
refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0161_09-01-2009.pdf
January 01, 2009 - populations, interventions, comparators, and outcomes, will be further developed in the
refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0456_07-27-2011.pdf
January 01, 2011 - populations, interventions, comparators, and outcomes, will be further
developed in the refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0288_03-10-2008.pdf
January 01, 2008 - populations, interventions, comparators, and outcomes, will be further developed in the refinement
phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0136_07-21-2009.pdf
January 01, 2009 - populations, interventions, comparators, and outcomes, will
be further developed in the refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0064_11-23-2008.pdf
January 01, 2008 - populations, interventions, comparators, and
outcomes, will be further developed in the refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0647-13114.pdf
June 21, 2013 - populations, interventions,
comparators, and outcomes, will be further developed in the refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-protocol.pdf
December 01, 2011 - Is it transitioning from one phase to another? If so, select.
b. … Is it transitioning from one phase to another? If so, select.
b. … Is it transitioning from one phase to another? If so, select.
b. … for track-only;
interventions with some preliminary phase III or later phase efficacy data are
considered … Phase of Development and Comment
9.
-
effectivehealthcare.ahrq.gov/products/labor-nitrous-oxide/research-protocol
May 11, 2011 - Additional discussions with the TEP following the public comment phase were also critical in shaping … The majority of comments received during the public comment phase were judgments regarding the effectiveness … Analytic Framework
Several comments were received during the public comment phase and TEP discussions … criteria developed based on our understanding of the literature developed during the topic refinement phase … Weekly during the review phase of the study, the Project Coordinator will report the number of abstracts
-
effectivehealthcare.ahrq.gov/products/lysosomal-storage-diseases-therapies/research-protocol
October 05, 2011 - We also sought prospective phase I or II nonrandomized studies that included patient subgroups with specific … If higher-level studies (RCTs, prospective phase I and II) were not available, case series (single-arm … not assess study quality or the overall strength of the evidence”
During the Topic Refinement phase … There also were a number of prospective phase I and II clinical studies that complemented the RCTs. … validity, we made a decision to compile the RCTs in the evidence map, supplementing them with prospective phase
-
effectivehealthcare.ahrq.gov/products/major-depressive-disorder/research
December 08, 2015 - medicine, and exercise treatment options as first-step interventions for adult outpatients with acute-phase
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1306.pdf
June 01, 2013 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in
phase … priority area this time (among the
11 topics being tracked as of May 18, 2013) for which (1) preliminary phase … The 6-month buprenorphine
implant completed phase III trials, one of which was funded by the National
-
effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1406.pdf
June 01, 2014 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in
phase … Results
The table below lists the one topic for which (1) preliminary phase III data were available; … These topics were ineligible for consideration in this report because no phase III data were
available
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0289_03-10-2008.pdf
January 01, 2008 - populations,
interventions, comparators, and outcomes, will be further developed in the refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0496_12-30-2011.pdf
January 01, 2011 - populations, interventions, comparators, and outcomes, will be further
developed in the refinement phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0477_11-01-2011.pdf
January 01, 2011 - populations, interventions, comparators, and outcomes, will be further developed in the
refinement phase